Oxurion Announces the Continuation of KALAHARI Phase 2, Part B Study in Diabetic Macular Edema Following Interim Analysis décembre 14, 20220CommentsEN Read More
Oxurion Receives Transparency Notifications from Negma Group décembre 13, 20220CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA décembre 12, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group décembre 7, 20220CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA décembre 6, 20220CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA décembre 2, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group décembre 2, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notifications from Negma Group novembre 28, 20220CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA novembre 25, 20220CommentsEN NL Read More
Noteringsprospectus d.d. 22 november 2022 novembre 22, 20220CommentsProspectus voor de toelating tot de handel op Euronext Brussels van maximaal 250.000.000 nieuwe aandelen Read More
Supplement op het Prospectus d.d. 22 november 2022 novembre 22, 20220CommentsSupplement op het Prospectus d.d. 22 november 2022 Read More
Simplified Listing Prospectus – November 22, 2022 novembre 22, 20220CommentsSimplified Listing Prospectus - November 22, 2022 Read More
Supplement to the Prospectus of 22 November 2022 novembre 22, 20220CommentsSupplement to the Prospectus of 22 November 2022 Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA novembre 18, 20220CommentsEN NL Read More
Oxurion Receives Transparency Notifications Based on New Denominator novembre 17, 20220CommentsEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA novembre 11, 20220CommentsEN NL Read More
